We spoke to Dr Luigi Di Biase (Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA) on the current and new, emerging treatment strategies for the treatment of persistent atrial fibrillation, including the limitations of current pulmonary vein isolation, the concept of “beyond PVI” and clinical evidence supporting new ablation targets.
- What are the limitations of current pulmonary vein isolation (PVI) strategies in the treatment of persistent atrial fibrillation (AF)? (0:18)
- Could you give us an overview of the new and emerging ablation targets in persistent AF? (3:07)
- What do you feel complicates the concept of “beyond PVI”? (4:55)
- What clinical evidence supports approaches involving new ablation targets? (6:46)
Speaker disclosures: Dr Di Biase is a consultant for Biosense Webster, Stereoataxis and Rhythm management and has received speaker honoraria/travel support from Biosense Webster, St. Jude Medical (now Abbott), Boston Scientific, Medtronic, Biotronik, Pfizer and Bristol Meyers Squibb.
Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Dr Luigi Biase as a highlight of the AF Symposium, January 2021.
Share this Video
Related Videos In Interventional Cardiology
Hyo-Soo Kim, ESC 2021 – HOST-EXAM Study
Dr Hyo-Soo Kim (Interventional Cardiologist, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) kindly shared his thoughts on the HOST-EXAM study and the effectiveness of clopidogrel versus aspirin for long-term maintenance after stenting, and the cost-effectiveness analysis from this data, from the virtual ESC Congress 2021. Questions What did the HOST-EXAM study teach us […]
Peter Smits, ESC 2021 – High Bleeding Risk After Coronary Stenting
Dr Peter Smits (Interventional Cardiologist, Maasstad Hospital, Rotterdam, The Netherlands) kindly shared his thoughts on the major challenges in the treatment of patients at high bleeding risk after coronary stenting, with an overview of the recent key clinical trials involving percutaneous coronary intervention with stent deployment in patients at high bleeding risk, from the virtual ESC […]
David Keane, AF Symposium 2021: Challenges in Catheter Ablation
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about the current challenges procedural duration and overall success in catheter ablation, and the most exciting innovations to aim to overcome these. Questions: What are the current challenges in catheter ablation in terms of procedural duration and overall success? (0.13) What are the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!